September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx...read more
Greenwich LifeSciences, a Phase 3 biotech developing immunotherapies for breast cancer, raised $7 million by offering 1.3 million shares (100% primary) at $5.75, the low end of the downwardly revised range of $5.75 to $6.75. The company originally planned to...read more
Greenwich LifeSciences, a Phase 3 biotech developing immunotherapies for breast cancer, lowered the proposed deal size for its upcoming IPO on Wednesday. The Stafford, TX-based company now plans to raise $18 million by offering 2.9 million shares (57%...read more
Updated Monday, 7/6. Following the long weekend, two Chinese IPOs, two biotechs, and a SPAC are currently scheduled to list in the US in the week ahead, inlcuding China’s largest LGBTQ dating app BlueCity (BLCT). More...read more
US IPO Weekly Recap: Health and tech dominate the calendar in an 11 IPO week
September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx...read more
Breast cancer biotech Greenwich LifeSciences prices IPO at $5.75, the low end of the downwardly revised range
Greenwich LifeSciences, a Phase 3 biotech developing immunotherapies for breast cancer, raised $7 million by offering 1.3 million shares (100% primary) at $5.75, the low end of the downwardly revised range of $5.75 to $6.75. The company originally planned to...read more
Breast cancer biotech Greenwich LifeSciences decreases deal size by 14% ahead of $18 million IPO
Greenwich LifeSciences, a Phase 3 biotech developing immunotherapies for breast cancer, lowered the proposed deal size for its upcoming IPO on Wednesday. The Stafford, TX-based company now plans to raise $18 million by offering 2.9 million shares (57%...read more
US IPO Week Ahead: Third quarter kicks off with China’s largest gay dating app
Updated Monday, 7/6. Following the long weekend, two Chinese IPOs, two biotechs, and a SPAC are currently scheduled to list in the US in the week ahead, inlcuding China’s largest LGBTQ dating app BlueCity (BLCT). More...read more